Expert Panel Flags Gaps in Mascot Health’s Diabetes FDC Trial, Seeks Revised Phase IV Protocol

New Delhi: The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) on Endocrinology and Metabolism has recommended Mascot Health Series Pvt Ltd to submit a revised Phase IV…

Continue ReadingExpert Panel Flags Gaps in Mascot Health’s Diabetes FDC Trial, Seeks Revised Phase IV Protocol

Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe

Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, CuraTeQ Biologics Pvt Ltd, has entered into a marketing and distribution agreement with Germany-based pharmaceutical company STADA Arzneimittel AG…

Continue ReadingAurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe

JB Chemicals Appoints Aman Mehta as MD, Expands Board with Three New Directors

Mumbai: J.B. Chemicals & Pharmaceuticals Limited has announced key changes to its board following shareholder approval via postal ballot, reinforcing its leadership structure and governance framework. The company has appointed…

Continue ReadingJB Chemicals Appoints Aman Mehta as MD, Expands Board with Three New Directors

Semaglutide Misuse Under Watch: Telangana DCA Issues Advisory After Generic Launch Surge

New Delhi: In response to the growing demand and widespread use of Semaglutide formulations following the patent expiry of innovator products in March 2026, the Drugs Control Administration (DCA), Telangana,…

Continue ReadingSemaglutide Misuse Under Watch: Telangana DCA Issues Advisory After Generic Launch Surge